Literature DB >> 16047122

The prospective clinical and scintigraphic assessment of patients with preserved left ventricular systolic function after transmyocardial laser revascularisation.

Miroslaw A Dziuk1, Ana Canizales, Nidhal Ali, Hany El-Deeb, Keith E Britton, Duncan S Dymond, Stephen J Edmondson.   

Abstract

AIM: To analyse the clinical outcome and myocardial perfusion and function after transmyocardial revascularisation (TMR) in patients with normal left ventricular function and multivessel coronary artery disease non-amenable for standard revascularisation. METHOD AND
RESULTS: Twenty three severely symptomatic patients (CCS score median 4) with normal left ventricular systolic function but coronaries non-amenable for either PTCA or CABG were subjected to TMR. The angina score, left ventricular systolic and diastolic function in radionuclide ventriculography at rest, exercise tolerance and myocardial perfusion--Thallium-201 SPECT (adenosine stress 74 and 37 MBq under nitrate cover) were evaluated before and 3, 6, 12 months post-operatively. After an average of 40 +/- 12 (range 14-56) TMR channels angina score decreased significantly (p< 0.0001) and the exercise tolerance increased (from 6.0 +/- 4.5 to 9.1 +/- 4.6 after 6 months, p< 0.05) in 21 patients. During the follow up period two patients had a myocardial infarction and one committed suicide after 6 months. Ejection fraction dropped significantly only after 1 year post-TMR from 70 +/- 13 to 63 +/- 0.13%, p < 0.05. The overall perfusion improved initially in 14 patients with subsequent deterioration in time. The changes in segmental perfusion were not associated with the symptomatic improvement.
CONCLUSION: Transmyocardial revascularisation in patients with normal ejection fraction may improve the angina class, exercise tolerance and overall but not segmental perfusion and does not show any immediate effect on left ventricular function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16047122     DOI: 10.1007/s10554-004-7987-x

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  30 in total

1.  Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease.

Authors:  O H Frazier; R J March; K A Horvath
Journal:  N Engl J Med       Date:  1999-09-30       Impact factor: 91.245

2.  Transmyocardial laser revascularization. Anatomic evidence of long-term channel patency.

Authors:  D A Cooley; O H Frazier; K A Kadipasaoglu; S Pehlivanoglu; R L Shannon; P Angelini
Journal:  Tex Heart Inst J       Date:  1994

3.  Improvement in inducible ischemia during dobutamine stress echocardiography after transmyocardial laser revascularization in patients with refractory angina pectoris.

Authors:  C L Donovan; K P Landolfo; J E Lowe; F Clements; R B Coleman; T Ryan
Journal:  J Am Coll Cardiol       Date:  1997-09       Impact factor: 24.094

4.  The transmyocardial laser revascularization international registry report.

Authors:  S M Burns; L D Sharples; S Tait; N Caine; J Wallwork; P M Schofield
Journal:  Eur Heart J       Date:  1999-01       Impact factor: 29.983

5.  Transmyocardial laser revascularization. Histological features in human nonresponder myocardium.

Authors:  N Gassler; H O Wintzer; H M Stubbe; A Wullbrand; U Helmchen
Journal:  Circulation       Date:  1997-01-21       Impact factor: 29.690

6.  A prospective, multicenter, randomized trial of percutaneous transmyocardial laser revascularization in patients with nonrecanalizable chronic total occlusions.

Authors:  Gregg W Stone; Paul S Teirstein; Ronald Rubenstein; Dwayne Schmidt; Patrick L Whitlow; Edward J Kosinski; Gregory Mishkel; John A Power
Journal:  J Am Coll Cardiol       Date:  2002-05-15       Impact factor: 24.094

7.  Early results of transmyocardial revascularization with a holmium laser.

Authors:  A Milano; S Pratali; G Tartarini; R Mariotti; M De Carlo; G Paterni; G Boni; U Bortolotti
Journal:  Ann Thorac Surg       Date:  1998-03       Impact factor: 4.330

8.  Transmyocardial laser revascularisation in patients with refractory angina: a randomised controlled trial.

Authors:  P M Schofield; L D Sharples; N Caine; S Burns; S Tait; T Wistow; M Buxton; J Wallwork
Journal:  Lancet       Date:  1999-02-13       Impact factor: 79.321

9.  Usefulness and safety of percutaneous myocardial laser revascularization for refractory angina pectoris.

Authors:  Mohammed Salem; Svein Rotevatn; Sindre Stavnes; Magne Brekke; Stein Emil Vollset; Jan Erik Nordrehaug
Journal:  Am J Cardiol       Date:  2004-05-01       Impact factor: 2.778

10.  Nontransmural laser treatment incompletely denervates canine myocardium.

Authors:  K F Kwong; R B Schuessler; G K Kanellopoulos; J E Saffitz; T M Sundt
Journal:  Circulation       Date:  1998-11-10       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.